ViewRay announces first MRIdian MRI-guided radiotherapy treatments begin in UK
ViewRay announced that the first MRIdian MRI-guided radiotherapy system in the United Kingdom - located at GenesisCare Oxford - has begun patient treatments. MRIdian combines high definition MRI imaging with linear accelerator radiation therapy to allow clinicians to visualize and adapt therapy as they treat tumors throughout the body. The first patient treated with MRIdian at Oxford was treated for prostate cancer using fully adapted stereotactic body radiation therapy, or SBRT. SBRT involves the delivery of higher doses of radiation than conventional radiation therapy in fewer treatment sessions. Using MRIdian's adaptive therapy capabilities, the radiation plan is optimized and adjusted to address movement and anatomical changes. This helps to ensure maximum coverage is achieved while sparing nearby tissue and organs in order to significantly reduce side effects.